Eledon Pharmaceuticals, Inc. (ELDN)

NASDAQ: ELDN · IEX Real-Time Price · USD

2.700

+0.050 (1.89%)

At close: Jul 19, 2024, 4:00 PM

2.690

-0.010 (-0.37%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Eledon Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Selling, General & Admin	13.15	12.69	12.7	13.13	10.05	6.06	Upgrade
Research & Development	29.61	30.31	27.08	23.74	6.13	8.13	Upgrade
Other Operating Expenses	0	0	48.65	0	2.28	1.87	Upgrade
Operating Expenses	42.76	43	88.43	36.87	18.47	16.05	Upgrade
Operating Income	-42.76	-43	-88.43	-36.87	-18.47	-16.05	Upgrade
Other Expense / Income	-2.91	-2.67	-0.46	-0.01	4.75	-0.04	Upgrade
Pretax Income	-39.85	-40.33	-87.97	-36.86	-23.22	-16.01	Upgrade
Income Tax	0	0	0	-2.35	-0.4	0	Upgrade
Net Income	-39.85	-40.33	-87.97	-34.51	-22.81	-16.01	Upgrade
Shares Outstanding (Basic)	30	25	14	15	1	1	Upgrade
Shares Outstanding (Diluted)	30	25	14	15	1	1	Upgrade
Shares Change	109.92%	72.34%	-3.61%	921.03%	121.41%	31.03%	Upgrade
EPS (Basic)	-1.38	-1.64	-6.16	-2.33	-15.72	-24.42	Upgrade
EPS (Diluted)	-1.38	-1.64	-6.16	-2.33	-15.72	-24.42	Upgrade
Free Cash Flow	-38.34	-39.53	-28.42	-28.91	-15.21	-13.86	Upgrade
Free Cash Flow Per Share	-1.28	-1.61	-1.99	-1.95	-10.48	-21.14	Upgrade
EBITDA	-39.47	-39.95	-87.59	-36.67	-23.03	-15.83	Upgrade
Depreciation & Amortization	0.38	0.37	0.37	0.2	0.18	0.18	Upgrade
EBIT	-39.85	-40.33	-87.97	-36.86	-23.22	-16.01	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).